{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:30:00Z","timestamp":1792272600322,"version":"4.4.0"},"reference-count":95,"publisher":"The Endocrine Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,6,1]]},"DOI":"10.1210\/jc.2012-3104","type":"journal-article","created":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T06:59:48Z","timestamp":1365058788000},"page":"2484-2493","source":"Crossref","is-referenced-by-count":123,"title":["Dysregulation of the Autonomic Nervous System Predicts the Development of the Metabolic Syndrome"],"prefix":"10.1210","volume":"98","author":[{"given":"Carmilla M. M.","family":"Licht","sequence":"first","affiliation":[{"name":"Department of Psychiatry (C.M.M.L., B.W.J.H.P.), Vrije Universiteit (VU) University Medical Center Amsterdam, The Netherlands"},{"name":"Extramural Medicine Research+ Institute (C.M.M.L., E.J.C.d.G., B.W.J.H.P.) for Health and Care Research, VU University Medical Center, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eco J. C.","family":"de Geus","sequence":"additional","affiliation":[{"name":"Extramural Medicine Research+ Institute (C.M.M.L., E.J.C.d.G., B.W.J.H.P.) for Health and Care Research, VU University Medical Center, Amsterdam, The Netherlands"},{"name":"Department of Biological Psychology (E.J.C.d.G.), VU University, Amsterdam, The Netherlands"},{"name":"Neuroscience Campus Amsterdam (E.J.C.d.G., B.W.J.H.P.), VU University Medical Center, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda W. J. H.","family":"Penninx","sequence":"additional","affiliation":[{"name":"Extramural Medicine Research+ Institute (C.M.M.L., E.J.C.d.G., B.W.J.H.P.) for Health and Care Research, VU University Medical Center, Amsterdam, The Netherlands"},{"name":"Neuroscience Campus Amsterdam (E.J.C.d.G., B.W.J.H.P.), VU University Medical Center, Amsterdam, The Netherlands"},{"name":"Department of Psychiatry (B.W.J.H.P.), Leiden University Medical Center, Leiden, The Netherlands"},{"name":"Department of Psychiatry (B.W.J.H.P.), University Medical Center Groningen, Groningen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"issue":"7540","key":"key\n\t\t\t\t2019041113321830500_B1","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1136\/bmj.38693.435301.80","article-title":"Chronic stress at work and the metabolic syndrome: prospective study","volume":"332","author":"Chandola","year":"2006","journal-title":"BMJ"},{"issue":"21","key":"key\n\t\t\t\t2019041113321830500_B2","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1161\/01.CIR.0000041502.43564.79","article-title":"Stress and the metabolic syndrome: an interesting but enigmatic association","volume":"106","author":"Hjemdahl","year":"2002","journal-title":"Circulation"},{"issue":"1","key":"key\n\t\t\t\t2019041113321830500_B3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psyneuen.2004.05.007","article-title":"Role of stress in the pathogenesis of the metabolic syndrome","volume":"30","author":"Rosmond","year":"2005","journal-title":"Psychoneuroendocrinology"},{"issue":"5","key":"key\n\t\t\t\t2019041113321830500_B4","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.2337\/db11-1142","article-title":"Hypothalamic neuropeptide Y (NPY) controls hepatic VLDL-triglyceride secretion in rats via the sympathetic nervous system","volume":"61","author":"Bruinstroop","year":"2012","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t2019041113321830500_B5","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1749-6632.2010.05800.x","article-title":"Hypothalamic control of energy metabolism via the autonomic nervous system","volume":"1212","author":"Kalsbeek","year":"2010","journal-title":"Ann NY Acad Sci"},{"issue":"7","key":"key\n\t\t\t\t2019041113321830500_B6","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1097\/01.hjh.0000234118.25401.1c","article-title":"Evolution of blood pressure and cholesterol in stage 1 hypertension: role of autonomic nervous system activity","volume":"24","author":"Palatini","year":"2006","journal-title":"J Hypertens"},{"issue":"2","key":"key\n\t\t\t\t2019041113321830500_B7","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1532-5415.2007.01564.x","article-title":"Higher levels of inflammation factors and greater insulin resistance are independently associated with higher heart rate and lower heart rate variability in normoglycemic older individuals: the Cardiovascular Health Study","volume":"56","author":"Stein","year":"2008","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"key\n\t\t\t\t2019041113321830500_B8","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1210\/jc.2011-2320","article-title":"Baseline sympathetic nervous system activity predicts dietary weight loss in obese metabolic syndrome subjects","volume":"97","author":"Straznicky","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"key\n\t\t\t\t2019041113321830500_B9","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1210\/jc.2009-2801","article-title":"Increased sympathetic and decreased parasympathetic activity rather than changes in hypothalamic-pituitary-adrenal axis activity is associated with metabolic abnormalities","volume":"95","author":"Licht","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"key\n\t\t\t\t2019041113321830500_B10","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jacc.2006.09.032","article-title":"Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies","volume":"49","author":"Gami","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"key\n\t\t\t\t2019041113321830500_B11","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.acvd.2008.06.011","article-title":"Recent advances in metabolic syndrome and cardiovascular disease","volume":"101","author":"Guize","year":"2008","journal-title":"Arch Cardiovasc Dis"},{"issue":"9","key":"key\n\t\t\t\t2019041113321830500_B12","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.2337\/dc08-0423","article-title":"Metabolic syndrome and incident diabetes: current state of the evidence","volume":"31","author":"Ford","year":"2008","journal-title":"Diabetes Care"},{"issue":"3","key":"key\n\t\t\t\t2019041113321830500_B13","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s12017-008-8022-5","article-title":"Perturbed autonomic nervous system function in metabolic syndrome","volume":"10","author":"Tentolouris","year":"2008","journal-title":"Neuromolecular Med"},{"issue":"21","key":"key\n\t\t\t\t2019041113321830500_B14","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1161\/01.CIR.0000038364.26310.BD","article-title":"Adrenocortical, autonomic, and inflammatory causes of the metabolic syndrome: nested case-control study","volume":"106","author":"Brunner","year":"2002","journal-title":"Circulation"},{"issue":"6","key":"key\n\t\t\t\t2019041113321830500_B15","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1161\/01.HYP.0000147893.08533.d8","article-title":"Sympathetic neural activation in nondiabetic metabolic syndrome and its further augmentation by hypertension","volume":"44","author":"Huggett","year":"2004","journal-title":"Hypertension"},{"issue":"10","key":"key\n\t\t\t\t2019041113321830500_B16","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.metabol.2009.04.028","article-title":"Differential sympathetic activation in muscle and skin neural districts in the metabolic syndrome","volume":"58","author":"Grassi","year":"2009","journal-title":"Metabolism"},{"issue":"4","key":"key\n\t\t\t\t2019041113321830500_B17","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1464-5491.2009.02686.x","article-title":"Metabolic syndrome and short-term heart rate variability in young adults. The cardiovascular risk in young Finns study","volume":"26","author":"Koskinen","year":"2009","journal-title":"Diabet Med"},{"issue":"12","key":"key\n\t\t\t\t2019041113321830500_B18","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.2337\/diacare.21.12.2116","article-title":"Multiple metabolic syndrome is associated with lower heart rate variability. The Atherosclerosis Risk in Communities Study","volume":"21","author":"Liao","year":"1998","journal-title":"Diabetes Care"},{"issue":"5","key":"key\n\t\t\t\t2019041113321830500_B19","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1540-8159.2008.01045.x","article-title":"The impact of the components of metabolic syndrome on heart rate variability: using the NCEP-ATP III and IDF definitions","volume":"31","author":"Min","year":"2008","journal-title":"Pacing Clin Electrophysiol"},{"issue":"4","key":"key\n\t\t\t\t2019041113321830500_B20","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/dmrr.2281","article-title":"Metabolic syndrome, physical activity and cardiac autonomic function","volume":"28","author":"Soares-Miranda","year":"2012","journal-title":"Diabetes Metab Res Rev"},{"issue":"2","key":"key\n\t\t\t\t2019041113321830500_B21","doi-asserted-by":"crossref","first-page":"96","DOI":"10.5271\/sjweh.2894","article-title":"Shift work and cardiovascular disease - pathways from circadian stress to morbidity","volume":"36","author":"Puttonen","year":"2010","journal-title":"Scand J Work Environ Health"},{"issue":"3","key":"key\n\t\t\t\t2019041113321830500_B22","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/mpr.256","article-title":"The Netherlands Study of Depression and Anxiety (NESDA): Rationale, Objectives and Methods","volume":"17","author":"Penninx","year":"2008","journal-title":"Int J Meth Psychiatr Res"},{"issue":"1","key":"key\n\t\t\t\t2019041113321830500_B23","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.comppsych.2011.01.011","article-title":"Sociodemographic and psychiatric determinants of attrition in the Netherlands Study of Depression and Anxiety (NESDA)","volume":"53","author":"Lamers","year":"2012","journal-title":"Compr Psychiatry"},{"issue":"9","key":"key\n\t\t\t\t2019041113321830500_B24","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.biopsych.2010.06.032","article-title":"Longitudinal evidence for unfavorable effects of antidepressants on heart rate variability","volume":"68","author":"Licht","year":"2010","journal-title":"Biol Psychiatry"},{"key":"key\n\t\t\t\t2019041113321830500_B25","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1600-0447.2010.01565.x","article-title":"Metabolic syndrome abnormalities are associated with severity of anxiety and depression and with tricyclic antidepressant use","volume":"122","author":"van Reedt Dortland","year":"2010","journal-title":"Acta Psychiatr Scand"},{"issue":"4","key":"key\n\t\t\t\t2019041113321830500_B26","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2165\/00129784-200606040-00001","article-title":"Metabolic effects of beta-adrenoceptor antagonists with special emphasis on carvedilol","volume":"6","author":"Kveiborg","year":"2006","journal-title":"Am J Cardiovasc Drugs"},{"issue":"3","key":"key\n\t\t\t\t2019041113321830500_B27","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/FJC.0b013e3181eb4ff2","article-title":"Nebivolol lowers blood pressure and increases weight loss in patients with hypertension and diabetes in regard to age","volume":"56","author":"Ladage","year":"2010","journal-title":"J Cardiovasc Pharmacol"},{"issue":"11","key":"key\n\t\t\t\t2019041113321830500_B28","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1038\/ijo.2010.284","article-title":"Metabolic sequelae of beta-blocker therapy: weighing in on the obesity epidemic?","volume":"35","author":"Lee","year":"2011","journal-title":"Int J Obes (Lond)"},{"issue":"2","key":"key\n\t\t\t\t2019041113321830500_B29","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0167-5273(97)00104-6","article-title":"Heart rate variability after acute myocardial infarction in patients treated with atenolol and metoprolol","volume":"60","author":"Lurje","year":"1997","journal-title":"Int J Cardiol"},{"issue":"9377","key":"key\n\t\t\t\t2019041113321830500_B30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(03)13800-7","article-title":"Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial","volume":"362","author":"Poole-Wilson","year":"2003","journal-title":"Lancet"},{"issue":"1","key":"key\n\t\t\t\t2019041113321830500_B31","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jacc.2005.04.011","article-title":"Beta-blocker treatment before angiotensin-converting enzyme inhibitor therapy in newly diagnosed heart failure","volume":"46","author":"Willenheimer","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"key\n\t\t\t\t2019041113321830500_B32","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"issue":"10","key":"key\n\t\t\t\t2019041113321830500_B33","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/eurheartj\/ehi235","article-title":"Heart rate: a strong predictor of mortality in subjects with coronary artery disease","volume":"26","author":"Palatini","year":"2005","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t2019041113321830500_B34","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.2337\/dc07-S004","article-title":"Standards of medical care in diabetes\u20142007","volume":"30","author":"American Diabetes Association","year":"2012","journal-title":"Diabetes Care"},{"issue":"4","key":"key\n\t\t\t\t2019041113321830500_B35","doi-asserted-by":"crossref","first-page":"641","DOI":"10.2337\/diacare.21.4.641","article-title":"Cardiovascular outcomes in type 2 diabetes. A double-blind placebo-controlled study of bezafibrate: the St. Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study","volume":"21","author":"Elkeles","year":"1998","journal-title":"Diabetes Care"},{"issue":"5","key":"key\n\t\t\t\t2019041113321830500_B36","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2165\/00003495-199652050-00008","article-title":"Bezafibrate. An update of its pharmacology and use in the management of dyslipidaemia","volume":"52","author":"Goa","year":"1996","journal-title":"Drugs"},{"key":"key\n\t\t\t\t2019041113321830500_B37","first-page":"H42","article-title":"Baseline characteristics of patients participating in the Bezafibrate Infarction Prevention (BIP) Study","volume":"19","author":"Goldbourt","year":"1998","journal-title":"Eur Heart J"},{"key":"key\n\t\t\t\t2019041113321830500_B38","first-page":"A62","article-title":"Overview of fenofibrate","volume":"19","author":"Packard","year":"1998","journal-title":"Eur Heart J"},{"issue":"6","key":"key\n\t\t\t\t2019041113321830500_B39","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1056\/NEJM199908053410604","article-title":"Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group","volume":"341","author":"Rubins","year":"1999","journal-title":"N Engl J Med"},{"issue":"6","key":"key\n\t\t\t\t2019041113321830500_B40","doi-asserted-by":"crossref","first-page":"982","DOI":"10.2165\/00003495-199651060-00009","article-title":"Gemfibrozil. A reappraisal of its pharmacological properties and place in the management of dyslipidaemia","volume":"51","author":"Spencer","year":"1996","journal-title":"Drugs"},{"issue":"9","key":"key\n\t\t\t\t2019041113321830500_B41","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S0002-9149(00)00703-7","article-title":"Multiple-dose efficacy and safety of an extended-release form of niacin in the management of hyperlipidemia","volume":"85","author":"Goldberg","year":"2000","journal-title":"Am J Cardiol"},{"issue":"8A","key":"key\n\t\t\t\t2019041113321830500_B42","doi-asserted-by":"crossref","first-page":"11i","DOI":"10.1016\/S0002-9149(02)02631-0","article-title":"Approach to lipoprotein management in 2001 National Cholesterol Guidelines","volume":"90","author":"Grundy","year":"2002","journal-title":"Am J Cardiol"},{"issue":"9","key":"key\n\t\t\t\t2019041113321830500_B43","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0026-0495(98)90284-0","article-title":"Equivalent efficacy of a time-release form of niacin (Niaspan) given once-a-night versus plain niacin in the management of hyperlipidemia","volume":"47","author":"Knopp","year":"1998","journal-title":"Metabolism"},{"issue":"11","key":"key\n\t\t\t\t2019041113321830500_B44","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1111\/j.1742-1241.2007.01514.x","article-title":"Correction of low HDL cholesterol to reduce cardiovascular risk: practical considerations relating to the therapeutic use of prolonged-release nicotinic acid (Niaspan)","volume":"61","author":"Vogt","year":"2007","journal-title":"Int J Clin Pract"},{"issue":"4","key":"key\n\t\t\t\t2019041113321830500_B45","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2147\/VHRM.S1023","article-title":"Prolonged-release nicotinic acid for the management of dyslipidemia: an update including results from the NAUTILUS study","volume":"3","author":"Vogt","year":"2007","journal-title":"Vasc Health Risk Manag"},{"issue":"24","key":"key\n\t\t\t\t2019041113321830500_B46","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1001\/jama.1991.03460240051027","article-title":"Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group","volume":"265","year":"1991","journal-title":"JAMA"},{"issue":"3","key":"key\n\t\t\t\t2019041113321830500_B47","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/00004872-200403000-00001","article-title":"Office compared with ambulatory blood pressure in assessing response to antihypertensive treatment: a meta-analysis","volume":"22","author":"Mancia","year":"2004","journal-title":"J Hypertens"},{"issue":"3","key":"key\n\t\t\t\t2019041113321830500_B48","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jclinepi.2005.08.008","article-title":"Simulation of the Syst-Eur randomized control trial using a primary care electronic medical record was feasible","volume":"59","author":"Tannen","year":"2006","journal-title":"J Clin Epidemiol"},{"issue":"3","key":"key\n\t\t\t\t2019041113321830500_B49","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0301-0511(95)05137-6","article-title":"Ambulatory measurement of respiratory sinus arrhythmia and respiration rate","volume":"41","author":"de Geus","year":"1995","journal-title":"Biol Psychol"},{"issue":"2","key":"key\n\t\t\t\t2019041113321830500_B50","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1469-8986.1996.tb02122.x","article-title":"Ambulatory monitoring of the impedance cardiogram","volume":"33","author":"Willemsen","year":"1996","journal-title":"Psychophysiology"},{"issue":"1","key":"key\n\t\t\t\t2019041113321830500_B51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1469-8986.1990.tb02171.x","article-title":"Methodological guidelines for impedance cardiography","volume":"27","author":"Sherwood","year":"1990","journal-title":"Psychophysiology"},{"issue":"4","key":"key\n\t\t\t\t2019041113321830500_B52","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1469-8986.2008.00652.x","article-title":"Cardiac autonomic balance versus cardiac regulatory capacity","volume":"45","author":"Berntson","year":"2008","journal-title":"Psychophysiology"},{"issue":"5","key":"key\n\t\t\t\t2019041113321830500_B53","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1469-8986.1993.tb02072.x","article-title":"Respiratory sinus arrhythmia, cardiac vagal tone, and respiration: within- and between-individual relations","volume":"30","author":"Grossman","year":"1993","journal-title":"Psychophysiology"},{"issue":"4","key":"key\n\t\t\t\t2019041113321830500_B54","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/01.psy.0000228010.96408.ed","article-title":"Implementation and interpretation of respiratory sinus arrhythmia measures in psychosomatic medicine: practice against better evidence?","volume":"68","author":"Ritz","year":"2006","journal-title":"Psychosom Med"},{"issue":"11","key":"key\n\t\t\t\t2019041113321830500_B55","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1161\/01.CIR.94.11.2850","article-title":"Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study","volume":"94","author":"Tsuji","year":"1996","journal-title":"Circulation"},{"issue":"2","key":"key\n\t\t\t\t2019041113321830500_B56","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1469-8986.1991.tb00412.x","article-title":"Prediction of tonic parasympathetic cardiac control using respiratory sinus arrhythmia: the need for respiratory control","volume":"28","author":"Grossman","year":"1991","journal-title":"Psychophysiology"},{"issue":"5","key":"key\n\t\t\t\t2019041113321830500_B57","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrn1902","article-title":"The sympathetic control of blood pressure","volume":"7","author":"Guyenet","year":"2006","journal-title":"Nat Rev Neurosci"},{"key":"key\n\t\t\t\t2019041113321830500_B58","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/01.RES.38.6.21","article-title":"Sympathetic nerve activity: role in regulation of blood pressure in the spontaenously hypertensive rat","volume":"38","author":"Judy","year":"1976","journal-title":"Circ Res"},{"issue":"7","key":"key\n\t\t\t\t2019041113321830500_B59","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/j.1464-5491.2010.03027.x","article-title":"Association between cardiac autonomic neuropathy and hypertension and its potential influence on diabetic complications","volume":"27","author":"Ayad","year":"2010","journal-title":"Diabet Med"},{"issue":"2","key":"key\n\t\t\t\t2019041113321830500_B60","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1161\/01.HYP.32.2.293","article-title":"Reduced heart rate variability and new-onset hypertension: insights into pathogenesis of hypertension: the Framingham Heart Study","volume":"32","author":"Singh","year":"1998","journal-title":"Hypertension"},{"issue":"1","key":"key\n\t\t\t\t2019041113321830500_B61","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/oby.2003.10","article-title":"Cardiovascular vagosympathetic activity in rats with ventromedial hypothalamic obesity","volume":"11","author":"Valensi","year":"2003","journal-title":"Obes Res"},{"issue":"6","key":"key\n\t\t\t\t2019041113321830500_B62","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1089\/rej.2010.1019","article-title":"Metabolic syndrome and short-term and long-term heart rate variability in elderly free of clinical cardiovascular disease: the PROOF study","volume":"13","author":"Assoumou","year":"2010","journal-title":"Rejuvenation Res"},{"issue":"4","key":"key\n\t\t\t\t2019041113321830500_B63","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/08964289.1994.9935186","article-title":"Serum lipids, neuroendocrine, and cardiovascular responses to stress in men and women with mild hypertension","volume":"19","author":"Burker","year":"1994","journal-title":"Behav Med"},{"key":"key\n\t\t\t\t2019041113321830500_B64","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/BF00120491","article-title":"Sympathoadrenergic overactivity and lipid metabolism","volume":"10","author":"Grynberg","year":"1996","journal-title":"Cardiovasc Drugs Ther"},{"issue":"2","key":"key\n\t\t\t\t2019041113321830500_B65","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1053\/meta.2001.19502","article-title":"Urinary epinephrine and norepinephrine interrelations with obesity, insulin, and the metabolic syndrome in Hong Kong Chinese","volume":"50","author":"Lee","year":"2001","journal-title":"Metabolism"},{"issue":"11","key":"key\n\t\t\t\t2019041113321830500_B66","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/clc.4960131104","article-title":"Alpha-adrenergic blockers: mechanism of action, blood pressure control, and effects of lipoprotein metabolism","volume":"13","author":"Nash","year":"1990","journal-title":"Clin Cardiol"},{"issue":"4","key":"key\n\t\t\t\t2019041113321830500_B67","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0026-0495(94)90085-X","article-title":"The relationship of epinephrine excretion to serum lipid levels: the Normative Aging Study","volume":"43","author":"Ward","year":"1994","journal-title":"Metabolism"},{"issue":"6","key":"key\n\t\t\t\t2019041113321830500_B68","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1097\/HJH.0b013e328346d787","article-title":"Association between plasma leptin and blood pressure in two population-based samples of children and adolescents","volume":"29","author":"Gr\u00f8ntved","year":"2011","journal-title":"J Hypertens"},{"issue":"1","key":"key\n\t\t\t\t2019041113321830500_B69","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1152\/jappl.1998.85.1.181","article-title":"Catecholamine effects on lipolysis and blood flow in human abdominal and femoral adipose tissue","volume":"85","author":"Millet","year":"1998","journal-title":"J Appl Physiol"},{"issue":"5","key":"key\n\t\t\t\t2019041113321830500_B70","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0895-7061(98)00035-1","article-title":"Heart rate variability and baroreflex sensitivity in hypertensive subjects with and without metabolic features of insulin resistance syndrome","volume":"11","author":"Pikkuj\u00e4ms\u00e4","year":"1998","journal-title":"Am J Hypertens"},{"issue":"1","key":"key\n\t\t\t\t2019041113321830500_B71","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s001090100198","article-title":"Regulation of leptin production: sympathetic nervous system interactions","volume":"79","author":"Rayner","year":"2001","journal-title":"J Mol Med (Berl)"},{"issue":"5","key":"key\n\t\t\t\t2019041113321830500_B72","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.2337\/db08-1595","article-title":"Weight loss may reverse blunted sympathetic neural responsiveness to glucose ingestion in obese subjects with metabolic syndrome","volume":"58","author":"Straznicky","year":"2009","journal-title":"Diabetes"},{"issue":"5","key":"key\n\t\t\t\t2019041113321830500_B73","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1161\/01.HYP.17.5.669","article-title":"Relation of obesity and diet to sympathetic nervous system activity","volume":"17","author":"Troisi","year":"1991","journal-title":"Hypertension"},{"issue":"11 pt 1","key":"key\n\t\t\t\t2019041113321830500_B74","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0895-7061(03)01015-X","article-title":"Influence of low high-density lipoprotein cholesterol on left ventricular hypertrophy and diastolic function in essential hypertension","volume":"16","author":"Horio","year":"2003","journal-title":"Am J Hypertens"},{"issue":"10","key":"key\n\t\t\t\t2019041113321830500_B75","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1751-7176.2011.00501.x","article-title":"Influence of low high-density lipoprotein cholesterol on arterial stiffening and left ventricular diastolic dysfunction in essential hypertension","volume":"13","author":"Miao","year":"2011","journal-title":"J Clin Hypertens (Greenwich )"},{"issue":"12","key":"key\n\t\t\t\t2019041113321830500_B76","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1097\/00004872-200112000-00021","article-title":"High-density lipoprotein cholesterol and left ventricular hypertrophy in essential hypertension","volume":"19","author":"Schillaci","year":"2001","journal-title":"J Hypertens"},{"key":"key\n\t\t\t\t2019041113321830500_B77","doi-asserted-by":"crossref","first-page":"247275","DOI":"10.1155\/2012\/247275","article-title":"Endoplasmic reticulum stress-associated lipid droplet formation and type ii diabetes","volume":"2012","author":"Zhang","year":"2012","journal-title":"Biochem Res Int"},{"issue":"1","key":"key\n\t\t\t\t2019041113321830500_B78","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1207\/s15327558ijbm0501_3","article-title":"Heart rate variability at rest and during mental stress in patients with coronary artery disease: differences in patients with high and low depression scores","volume":"5","author":"Sheffield","year":"1998","journal-title":"Int J Behav Med"},{"issue":"6","key":"key\n\t\t\t\t2019041113321830500_B79","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1097\/00006842-200011000-00009","article-title":"Depressed mood is related to high-frequency heart rate variability during stressors","volume":"62","author":"Hughes","year":"2000","journal-title":"Psychosom Med"},{"issue":"4","key":"key\n\t\t\t\t2019041113321830500_B80","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/01.psy.0000170335.92770.7a","article-title":"A greater reduction in high-frequency heart rate variability to a psychological stressor is associated with subclinical coronary and aortic calcification in postmenopausal women","volume":"67","author":"Gianaros","year":"2005","journal-title":"Psychosom Med"},{"issue":"2","key":"key\n\t\t\t\t2019041113321830500_B81","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1469-8986.1993.tb01731.x","article-title":"Respiratory sinus arrhythmia: autonomic origins, physiological mechanisms, and psychophysiological implications","volume":"30","author":"Berntson","year":"1993","journal-title":"Psychophysiology"},{"issue":"5","key":"key\n\t\t\t\t2019041113321830500_B82","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/01.psy.0000138283.65547.78","article-title":"Overcommitment to work is associated with changes in cardiac sympathetic regulation","volume":"66","author":"Vrijkotte","year":"2004","journal-title":"Psychosom Med"},{"issue":"3","key":"key\n\t\t\t\t2019041113321830500_B83","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ijpsycho.2011.06.007","article-title":"Underestimation of cardiac vagal control in regular exercisers by 24-hour heart rate variability recordings","volume":"81","author":"van Lien","year":"2011","journal-title":"Int J Psychophysiol"},{"issue":"1","key":"key\n\t\t\t\t2019041113321830500_B84","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11892-009-0090-x","article-title":"Cholesterol in beta-cell dysfunction: the emerging connection between HDL cholesterol and type 2 diabetes","volume":"10","author":"Brunham","year":"2010","journal-title":"Curr Diab Rep"},{"issue":"3","key":"key\n\t\t\t\t2019041113321830500_B85","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.pharmthera.2006.02.003","article-title":"Therapeutic elevation of HDL-cholesterol to prevent atherosclerosis and coronary heart disease","volume":"111","author":"Chapman","year":"2006","journal-title":"Pharmacol Ther"},{"key":"key\n\t\t\t\t2019041113321830500_B86","article-title":"How to control residual cardiovascular risk despite statin treatment: focusing on HDL-cholesterol [published online April 12, 2012]","author":"Lim","journal-title":"Int J Cardiol"},{"issue":"9","key":"key\n\t\t\t\t2019041113321830500_B87","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.2337\/diacare.23.9.1359","article-title":"Familial clustering of arterial blood pressure, HDL cholesterol, and pro-insulin but not of insulin resistance and microalbuminuria in siblings of patients with type 2 diabetes","volume":"23","author":"Pontiroli","year":"2000","journal-title":"Diabetes Care"},{"issue":"2","key":"key\n\t\t\t\t2019041113321830500_B88","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.atherosclerosis.2010.08.080","article-title":"Pulse wave analysis and prevalent cardiovascular disease in type 1 diabetes","volume":"213","author":"Prince","year":"2010","journal-title":"Atherosclerosis"},{"issue":"1","key":"key\n\t\t\t\t2019041113321830500_B89","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2967\/jnumed.108.055194","article-title":"The significance of cardiac sympathetic nervous system abnormality in the long-term prognosis of patients with a history of ventricular tachyarrhythmia","volume":"50","author":"Akutsu","year":"2009","journal-title":"J Nucl Med"},{"issue":"4","key":"key\n\t\t\t\t2019041113321830500_B90","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1007\/s00259-009-1322-7","article-title":"Significance of cardiac sympathetic nervous system abnormality for predicting vascular events in patients with idiopathic paroxysmal atrial fibrillation","volume":"37","author":"Akutsu","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"key\n\t\t\t\t2019041113321830500_B91","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/0735-1097(93)90106-B","article-title":"Frequency domain measures of heart period variability to assess risk late after myocardial infarction","volume":"21","author":"Bigger","year":"1993","journal-title":"J Am Coll Cardiol"},{"issue":"17","key":"key\n\t\t\t\t2019041113321830500_B92","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1161\/hc4201.097834","article-title":"Depression, heart rate variability, and acute myocardial infarction","volume":"104","author":"Carney","year":"2001","journal-title":"Circulation"},{"issue":"11","key":"key\n\t\t\t\t2019041113321830500_B93","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1161\/01.CIR.102.11.1239","article-title":"Low heart rate variability in a 2-minute rhythm strip predicts risk of coronary heart disease and mortality from several causes: the ARIC Study. Atherosclerosis Risk In Communities","volume":"102","author":"Dekker","year":"2000","journal-title":"Circulation"},{"issue":"5","key":"key\n\t\t\t\t2019041113321830500_B94","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.amjcard.2011.10.025","article-title":"Usefulness of heart rate to predict cardiac events in treated patients with high-risk systemic hypertension","volume":"109","author":"Julius","year":"2012","journal-title":"Am J Cardiol"},{"issue":"1","key":"key\n\t\t\t\t2019041113321830500_B95","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00004872-199715010-00001","article-title":"Heart rate and the cardiovascular risk","volume":"15","author":"Palatini","year":"1997","journal-title":"J Hypertens"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/98\/6\/2484\/10423798\/jcem2484.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T20:16:56Z","timestamp":1562876216000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/98\/6\/2484\/2537184"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6,1]]},"references-count":95,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2012-3104","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,6,1]]}}}